• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏再同步治疗中优化左心室电极放置的植入前评估:心电图、超声心动图还是磁共振成像?

Pre-Implant Assessment For Optimal LV Lead Placement In CRT: ECG, ECHO, or MRI?

作者信息

Singleton Matthew J, Spragg David D

机构信息

Johns Hopkins Hospital and Johns Hopkins Bayview Medical Center, Baltimore, MD.

出版信息

J Atr Fibrillation. 2015 Aug 31;8(2):1280. doi: 10.4022/jafib.1280. eCollection 2015 Aug-Sep.

DOI:10.4022/jafib.1280
PMID:27957193
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5135171/
Abstract

Cardiac resynchronization therapy (CRT) improves cardiac function in many patients with ventricular dyssynchrony. The optimal use of imaging for pre-implantation assessment remains a subject of debate. Here, we review the literature to date on the utility of echocardiography and cardiac MR, as well as conventional ECG, in choosing the best site for LV lead implantation. Prior to the use of imaging for pre-implantation evaluation, LV leads were placed empirically, based on average responses from population-level studies. Subsequently, patient-specific approaches have been used to maximize response. Both echocardiography and cardiac MR allow determination of areas of latest mechanical activation. Some studies have found improved response when pacing is applied at or near the site of latest mechanical activation. Similarly, both echocardiography and cardiac MR provide information about the location of any myocardial scar, which should be avoided when placing the LV lead due to variable conduction and high capture thresholds. Alternative approaches include targeting the region of latest electrical activation via measurement of the QLV interval and methods based on intraoperative hemodynamic measurements. Each of these modalities offers complementary insights into LV lead placement, so future directions include multimodality pre-implantation evaluation, studies of which are ongoing. Emerging technologies such as leadless implantable pacemakers may free implanting electrophysiologists from the constraints of the coronary sinus, making this information more useful and making non-response to CRT increasingly rare.

摘要

心脏再同步治疗(CRT)可改善许多存在心室不同步的患者的心脏功能。对于植入前评估而言,影像学检查的最佳应用仍存在争议。在此,我们回顾了迄今为止关于超声心动图、心脏磁共振成像以及传统心电图在选择左心室电极植入最佳部位方面的文献。在使用影像学进行植入前评估之前,左心室电极是根据人群水平研究的平均反应经验性放置的。随后,采用了针对个体患者的方法来使反应最大化。超声心动图和心脏磁共振成像都能确定最晚机械激活区域。一些研究发现,在最晚机械激活部位或其附近进行起搏时反应有所改善。同样,超声心动图和心脏磁共振成像都能提供有关任何心肌瘢痕位置的信息,由于传导可变和捕捉阈值较高,在放置左心室电极时应避开这些部位。其他方法包括通过测量QLV间期来靶向最晚电激活区域以及基于术中血流动力学测量的方法。这些方法中的每一种都为左心室电极放置提供了互补的见解,因此未来的方向包括多模态植入前评估,相关研究正在进行中。诸如无导线植入式起搏器等新兴技术可能使植入电生理学家摆脱冠状窦的限制,使这些信息更有用,并使CRT无反应的情况越来越罕见。

相似文献

1
Pre-Implant Assessment For Optimal LV Lead Placement In CRT: ECG, ECHO, or MRI?心脏再同步治疗中优化左心室电极放置的植入前评估:心电图、超声心动图还是磁共振成像?
J Atr Fibrillation. 2015 Aug 31;8(2):1280. doi: 10.4022/jafib.1280. eCollection 2015 Aug-Sep.
2
Non-invasive estimation of QLV from the standard 12-lead ECG in patients with left bundle branch block.左束支传导阻滞患者中基于标准12导联心电图对左心室容积进行无创估计。
Front Physiol. 2022 Sep 21;13:939240. doi: 10.3389/fphys.2022.939240. eCollection 2022.
3
Multimodality imaging-guided left ventricular lead placement in cardiac resynchronization therapy: a randomized controlled trial.多模态影像引导下心脏再同步治疗的左心室导线放置:一项随机对照试验。
Eur J Heart Fail. 2016 Nov;18(11):1365-1374. doi: 10.1002/ejhf.530. Epub 2016 Apr 18.
4
Optimizing CRT - Do We Need More Leads and Delivery Methods.优化心脏再同步治疗——我们是否需要更多电极导线和输送方法。
J Atr Fibrillation. 2015 Apr 30;7(6):1202. doi: 10.4022/jafib.1202. eCollection 2015 Apr-May.
5
Assessment of mechanical dyssynchrony in cardiac resynchronization therapy.心脏再同步治疗中机械性不同步的评估。
Dan Med J. 2014 Dec;61(12):B4981.
6
Imaging left-ventricular mechanical activation in heart failure patients using cine DENSE MRI: Validation and implications for cardiac resynchronization therapy.应用电影 DENSE MRI 成像技术评估心力衰竭患者左心室机械激活:对心脏再同步治疗的验证和影响。
J Magn Reson Imaging. 2017 Sep;46(3):887-896. doi: 10.1002/jmri.25613. Epub 2017 Jan 9.
7
Influence of pacing site characteristics on response to cardiac resynchronization therapy.起搏部位特征对心脏再同步治疗反应的影响。
Circ Cardiovasc Imaging. 2013 Jul;6(4):542-50. doi: 10.1161/CIRCIMAGING.111.000146. Epub 2013 Jun 5.
8
Different regions of latest electrical activation during left bundle-branch block and right ventricular pacing in cardiac resynchronization therapy patients determined by coronary venous electro-anatomic mapping.冠状静脉电解剖标测指导下左束支阻滞和右心室起搏时心脏再同步治疗患者的最新电激动不同区域。
Eur J Heart Fail. 2014 Nov;16(11):1214-22. doi: 10.1002/ejhf.178. Epub 2014 Oct 15.
9
Prognostic benefit of optimum left ventricular lead position in cardiac resynchronization therapy: follow-up of the TARGET Study Cohort (Targeted Left Ventricular Lead Placement to guide Cardiac Resynchronization Therapy).心脏再同步治疗中最佳左心室导线位置的预后获益:TARGET 研究队列的随访结果(靶向左心室导线位置指导心脏再同步治疗)。
JACC Heart Fail. 2014 Jun;2(3):205-12. doi: 10.1016/j.jchf.2013.11.010.
10
Longer inter-lead electrical delay is associated with response to cardiac resynchronization therapy in patients with presumed optimal left ventricular lead position.电间期延长与假定左心室起搏部位优化患者对心脏再同步治疗的反应相关。
Europace. 2018 Oct 1;20(10):1630-1637. doi: 10.1093/europace/eux384.

引用本文的文献

1
The Role of Echocardiography in the Optimization of Cardiac Resynchronization Therapy: Current Evidence and Future Perspectives.超声心动图在心脏再同步治疗优化中的作用:当前证据与未来展望
Open Cardiovasc Med J. 2017 Dec 19;11:133-145. doi: 10.2174/1874192401711010133. eCollection 2017.

本文引用的文献

1
Model-based navigation of left and right ventricular leads to optimal targets for cardiac resynchronization therapy: a single-center feasibility study.基于模型的左右心室导线导航至心脏再同步治疗的最佳靶点:一项单中心可行性研究。
Circ Arrhythm Electrophysiol. 2014 Dec;7(6):1040-7. doi: 10.1161/CIRCEP.114.001729. Epub 2014 Sep 14.
2
Meta-analysis of effects of optimization of cardiac resynchronization therapy on left ventricular function, exercise capacity, and quality of life in patients with heart failure.心脏再同步化治疗优化对心力衰竭患者左心室功能、运动能力和生活质量影响的荟萃分析。
Am J Cardiol. 2014 Mar 15;113(6):988-94. doi: 10.1016/j.amjcard.2013.12.006. Epub 2013 Dec 25.
3
Impact of nonischemic scar features on local ventricular electrograms and scar-related ventricular tachycardia circuits in patients with nonischemic cardiomyopathy.非缺血性瘢痕特征对非缺血性心肌病患者局部心室电图和与瘢痕相关的室性心动过速环的影响。
Circ Arrhythm Electrophysiol. 2013 Dec;6(6):1139-47. doi: 10.1161/CIRCEP.113.000159. Epub 2013 Nov 14.
4
Usefulness of echocardiographically guided left ventricular lead placement for cardiac resynchronization therapy in patients with intermediate QRS width and non-left bundle branch block morphology.超声心动图引导左心室导线放置在 QRS 宽度中等且无左束支传导阻滞形态的患者心脏再同步治疗中的作用。
Am J Cardiol. 2014 Jan 1;113(1):107-16. doi: 10.1016/j.amjcard.2013.09.024. Epub 2013 Oct 3.
5
Empiric versus imaging guided left ventricular lead placement in cardiac resynchronization therapy (ImagingCRT): study protocol for a randomized controlled trial.经验性与影像学指导心脏再同步治疗左心室导线植入的比较(ImagingCRT):一项随机对照试验的研究方案。
Trials. 2013 Apr 26;14:113. doi: 10.1186/1745-6215-14-113.
6
Echocardiography-guided left ventricular lead placement for cardiac resynchronization therapy: results of the Speckle Tracking Assisted Resynchronization Therapy for Electrode Region trial.超声心动图引导左心室导线放置在心脏再同步治疗中的应用:斑点追踪辅助再同步治疗电极区域试验的结果。
Circ Heart Fail. 2013 May;6(3):427-34. doi: 10.1161/CIRCHEARTFAILURE.112.000078. Epub 2013 Mar 8.
7
ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation appropriate use criteria task force, Heart Rhythm Society, American Heart Association, American Society of Echocardiography, Heart Failure Society of America, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance.ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013年植入式心脏复律除颤器及心脏再同步治疗的合理应用标准:美国心脏病学基金会合理应用标准工作组、心律学会、美国心脏协会、美国超声心动图学会、美国心力衰竭学会、心血管造影和介入学会、心血管计算机断层扫描学会以及心血管磁共振学会的报告
Heart Rhythm. 2013 Apr;10(4):e11-58. doi: 10.1016/j.hrthm.2013.01.008. Epub 2013 Mar 7.
8
Resynchronization improves heart-arterial coupling reducing arterial load determinants.再同步化改善了心-动脉偶联,降低了动脉负荷决定因素。
Europace. 2013 Apr;15(4):554-65. doi: 10.1093/europace/eus285. Epub 2012 Nov 9.
9
Long-term mortality with cardiac resynchronization therapy in the Cardiac Resynchronization-Heart Failure (CARE-HF) trial.心脏再同步治疗心力衰竭(CARE-HF)试验的长期死亡率。
Eur J Heart Fail. 2012 Jun;14(6):628-34. doi: 10.1093/eurjhf/hfs055. Epub 2012 May 2.
10
Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial.靶向左心室导线放置指导心脏再同步治疗:TARGET 研究:一项随机对照试验。
J Am Coll Cardiol. 2012 Apr 24;59(17):1509-18. doi: 10.1016/j.jacc.2011.12.030. Epub 2012 Mar 7.